Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) insider Adam Vandervoort sold 7,906 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total value of $60,322.78. Following the completion of the sale, the insider directly owned 110,261 shares of the company’s stock, valued at approximately $841,291.43. This trade represents a 6.69% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Teladoc Health Price Performance
Teladoc Health stock opened at $7.05 on Friday. Teladoc Health, Inc. has a one year low of $4.40 and a one year high of $9.77. The company has a debt-to-equity ratio of 0.75, a quick ratio of 2.72 and a current ratio of 2.80. The business has a fifty day moving average of $6.20 and a two-hundred day moving average of $6.22. The company has a market cap of $1.27 billion, a P/E ratio of -7.26 and a beta of 2.14.
Teladoc Health (NYSE:TDOC – Get Free Report) last announced its quarterly earnings results on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.01). Teladoc Health had a negative net margin of 6.81% and a negative return on equity of 11.45%. The firm had revenue of $613.85 million during the quarter, compared to analysts’ expectations of $611.04 million. During the same quarter in the prior year, the business earned ($0.53) EPS. The company’s quarterly revenue was down 2.5% compared to the same quarter last year. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. As a group, analysts predict that Teladoc Health, Inc. will post -0.92 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Read Our Latest Research Report on Teladoc Health
Institutional Trading of Teladoc Health
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. EverSource Wealth Advisors LLC increased its position in Teladoc Health by 694.5% during the 1st quarter. EverSource Wealth Advisors LLC now owns 5,657 shares of the health services provider’s stock worth $31,000 after purchasing an additional 4,945 shares in the last quarter. PNC Financial Services Group Inc. increased its position in Teladoc Health by 177.7% during the 4th quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock worth $31,000 after purchasing an additional 2,810 shares in the last quarter. IFP Advisors Inc increased its position in Teladoc Health by 412.1% during the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock worth $31,000 after purchasing an additional 3,210 shares in the last quarter. Aster Capital Management DIFC Ltd increased its position in Teladoc Health by 101.1% during the 3rd quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock worth $37,000 after purchasing an additional 2,425 shares in the last quarter. Finally, International Assets Investment Management LLC purchased a new stake in Teladoc Health during the 4th quarter worth about $45,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.
About Teladoc Health
Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.
Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.
Featured Articles
- Five stocks we like better than Teladoc Health
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.
